Recent Headlines
Within Drug Delivery Systems
Cannabis Manifesto Issues Urgent Wake-Up Call to Global Society
The Dà Má Collective has released "Dissolving The Stigma Against Nature’s Oldest & Safest Medicine: a manifesto," which aims to correct public opinion towards the healing herb known as cannabis. The 7-page illustrated manifesto makes the case, supported by 11,000+ years of hard evidence, that any stigma surrounding the use of cannabis (the notion that cannabis is somehow ‘naughty’) is unfounded and unsustainable. - September 06, 2016 - The Da Ma Collective
KinderPharm to Celebrate Grand Opening of New Exton Office
Pennsylvania Elected Officials to Participate in Ribbon-Cutting Ceremony and Grand Opening Event; KinderPharm is pleased to announce that it will hold a Grand Opening event and Ribbon-Cutting ceremony for its new office at 100 Arrandale Blvd., Exton, Pennsylvania on Friday, August 26th from 1 p.m. to 3 p.m. The event will feature a ribbon-cutting ceremony at 1 p.m., food and refreshments, and industry networking. - August 16, 2016 - KinderPharm LLC
TruInject Founder Gabrielle Rios Receives Nomination for Innovator of the Year from the Orange County Business Journal
TruInject Medical Corp™ is pleased to announce the nomination of Innovator of the Year by the Orange County Business Journal. - August 09, 2016 - Truinject Medical Corp.
Tabula Rasa HealthCare's Jack Russell Software Innovation Center Kick Off First JRS Coding School Boot Camp September 19
The Jack Russell Software Innovation Center (JRS IC) announced today its first Coding School Boot Camp will be held September 19, - December 6, 2016. Applications must be submitted between August 1 – September 1, 2016. The JRS IC was launched this year by TRHC to develop technology that will solve real health care problems while providing leading-edge value to software innovation. In celebration, a 50% discount off of the tuition is being offered to students. - August 05, 2016 - Tabula Rasa HealthCare
Tabula Rasa HealthCare Launches Jack Russell Software Innovation Center; Tom Wilson Named Executive VP/Chief Technology Innovation Officer
The new JRS IC will provide technology leadership, creativity and training to TRHC and its subsidiaries, as well as the healthcare community at large. Programs and events are designed to engage and collaborate with highly trained professionals in fields of software development, while creating a culture that continuously innovates and focuses on patient safety. - August 05, 2016 - Tabula Rasa HealthCare
Saffa Compounding Pharmacy/Sunshine Care Partners Tulsa. Saffa Pharmacy Announced as Sunshine Care Partners Territory License Owner for Tulsa County, OK.
Saffa Compounding Pharmacy is proud to announce its purchase of the Sunshine Care Partners, Tulsa County Territory, and welcomes territory owners Debra Wells DPh, and Karla Taylor, both residents of Tulsa County. Tulsa County physicians serving Chronic Care Patients can partner with Saffa/Sunshine who, after serving the community for over 42 years, is expanding their services to both physicians and patients. - July 07, 2016 - Saffa Compounding Pharmacy
Tabula Rasa HealthCare Subsidiary Medliance Promotes Rebstock to Executive Director
TRHC Chairman and CEO Calvin H. Knowlton named Candy Rebstock Executive Director of its wholly-owned subsidiary, Medliance, which is the leading pharmacy cost management solution for post-acute care. Clients rely on Medliance's adjudication and consulting services to create transparency and increase communication between client skilled nursing facilities and their pharmacy partners. - June 20, 2016 - Tabula Rasa HealthCare
Tabula Rasa HealthCare CEO Calvin H. Knowlton Named Technology CEO of the Year
Tabula Rasa HealthCare Chairman and CEO, Calvin H. Knowlton, received the 2016 PACT Enterprise Award for Technology CEO of the Year at a gala event in Philadelphia, May 12. While accepting the award, Knowlton stated, "TRHC results include enhanced medication-related outcomes and greater operational efficiency. The work we are doing in medication informatics, personalized medication management, and compliance/assurance is exciting and, we believe, game changing." - June 03, 2016 - Tabula Rasa HealthCare
NJHA Brings Medication Risk Mitigation Services to New Jersey Hospitals Through Strategic Alliance with Tabula Rasa HealthCare
New Jersey Hospital Association and Tabula Rasa HealthCare (TRHC) have entered into a 3-year agreement to offer TRHC's proprietary Medication Risk Mitigation™ products and services to NJHA’s nearly 400 member healthcare organizations. - May 02, 2016 - Tabula Rasa HealthCare
Tabula Rasa HealthCare Names Kristen Propp Creative Director; Healthcare Technology Company Expands Marketing Heft with New Hire
Tabula Rasa HealthCare, Inc. (TRHC) President Orsula V. Knowlton announced graphic designer, Kristen Propp, has joined the healthcare technology company as Creative Director. TRHC is a leader in providing patient-specific, data-driven technology and solutions for health care organizations. - May 02, 2016 - Tabula Rasa HealthCare
Tabula Rasa HealthCare CIO Receives 2016 Executive Management Award
Tabula Rasa HealthCare CIO Joseph J. Filippoli was honored by SmartCEO Magazine with the 2016 Executive Management Award at a gala celebration March 8. The award recognizes the "leadership and accomplishments of Philadelphia's management all-stars. Winners are recognized for their creative management vision, leadership philosophy, innovative strategy and undeniable work ethic." - March 11, 2016 - Tabula Rasa HealthCare
Wego Health to Demonstrate the Importance of Patient Influencers During ePharma Summit 2016
Company will ask for a single question to show how the pharmaceutical industry can benefit from engaging patient community leaders. - February 24, 2016 - Wego Health
Tabula Rasa Healthcare Pharmacy Simulation Software Tested by Schools of Pharmacy
Medication treatment is the most common medical intervention. Its imprecise use contributes to an estimated 45-50 million adverse drug events annually. Tabula Rasa's suite of software solutions provide prescribers, pharmacists and healthcare organizations with sophisticated and innovative tools to better manage the medication-related needs of patients. NiaRx provides electronic health record training and patient-case simulation for pharmacy students, the future of tomorrow's caregiving team. - February 15, 2016 - Tabula Rasa HealthCare
Coalition Forms to Study Medication Risk in Workforce Populations
Tabula Rasa HealthCare and The Greater Philadelphia Business Coalition on Health have partnered to examine the extent of medication risk in a diverse workforce population and the opportunities to mitigate that risk for the benefit of improving the health and welfare of employees and reducing unnecessary health care costs. - February 01, 2016 - Tabula Rasa HealthCare
Tabula Rasa HealthCare Responds to CMS Announcement of Part D Enhanced Medication Therapy Managment Model
Under the CMS Enhanced MTM Model, the personalized MTM services offered by Tabula Rasa HealthCare are now eligible for reimbursement by CMS, and for additional performance-based payments. TRHC's Medication Risk Mitigation Matrix(TM) has proven to reduce adverse drug reactions. - October 29, 2015 - Tabula Rasa HealthCare
Tabula Rasa HealthCare CEO Named 2015 Health Care Innovator of the Year
Calvin H. Knowlton, Chairman and CEO, Tabula Rasa HealthCare, Inc. has been named Individual Health Care Innovator of the Year by the Philadelphia Business Journal. Knowlton is being recognized for his innovation in medication risk mitigation and personalized medicine. - October 20, 2015 - Tabula Rasa HealthCare
Oak Street Health and Tabula Rasa Healthcare Aim to Improve Patient Outcomes Through Optimization of Medication Regimens
Program's goal is to improve the safety of patient medication regimens and patient outcomes using Tabula Rasa's novel and proprietary MRM technolgy platform in tandem with the automated, robotic dispensary of TRHC's CareKinesis Pharmacy. - October 15, 2015 - Tabula Rasa HealthCare
Gensco Laboratories Supports World Arthritis Day on October 12, 2015
Gensco Laboratories, a specialty pharmaceutical company, has recently introduced a new transdermal prescription medication that provides rapid relief at the first sign of an acute gout flare, ColciGel®, indicated for the treatment and prophylaxis of acute gout flares in adults. ColciGel® is easy to apply directly on the site of pain and each bottle has Metered Dose Technology (MDose™) which dispenses the exact amount of transdermal medication. - October 12, 2015 - Gensco Labs
KinderPharm LLC Acquires Clinical Pharmacology and Pharmacometric Research and Development Company
KinderPharm LLC., announced that it has acquired PKPD Bioscience, Inc., a clinical pharmacology and pharmacometric research and development company. The purchase will strengthen the capabilities of KinderPharm LLC to provide pediatric PK/PD modeling and simulation as well as Pop PK and sparse sampling. - September 01, 2015 - KinderPharm LLC
KinderPharm Raises $1 Million to Further Advance Pediatric Drug Development
KinderPharm, a full-service contract research organization (CRO) dedicated exclusively to pediatric drug development, has raised $1 million from a Series A comprised of individuals, companies and angel investors. The $1 million investment will be used to further advance the clinical development of new medicines for children. - August 13, 2015 - KinderPharm LLC
Gensco Labs Announces LiDORx® Copay Program Mobile Platform for Pain Management
Text “LIDO to 37500” on your mobile device to receive the benefits of the Program Gensco Laboratories™ (www.genscolabs.com), A Specialty Pharmaceutical Company, announces a new mobile platform that uses innovative smart phone technology to provide copay assistance and facilitate... - August 11, 2015 - Gensco Labs
GenToX is Now Offering Inherited Cancer Testing
Industry Leader in Pharmacogenomics is now offering inherited cancer screenings for patients to enhance their personalized medical testing services. - July 10, 2015 - GenToX
Creative BioMart Introduces Oxidative Stress Assay
Creative BioMart, a global leader in the supply of innovative protein research tools and services announced today that it has launched exclusive Oxidative Stress Assay for use in studying many forms of pathophysiology generally associated with aging. Oxidative stress can reflect a disturbance... - June 07, 2015 - Creative Biomart
Tabula Rasa HealthCare Receives Top Innovator Company Award
Tabula Rasa HealthCare is recognized for its "innovative solutions that are making an impact on cost, quality, and access in health care." TRHC develops offerings for the ever-growing segment of the healthcare system that is "at risk," providing tools and services to better manage risk. - June 05, 2015 - Tabula Rasa HealthCare
Truinject Training System to Provide Real-Time Feedback for Cosmetic Injectors
TruInject Medical Corp™ is pleased to announce the development and pending launch of the TruInject Training System, the first injectable simulation system featuring true-to-life tissue, 3D digital facial anatomy and real-time feedback. - June 05, 2015 - Truinject Medical Corp.
Linking API Producers to API Customers - Connectivity Matters
The API Sourcing Database is a new Database to find producers of Active Pharmaceutical Ingredients including up to date quality information about the API. - June 02, 2015 - API Sourcing
Creative Biomart Launches an Intuitive New Website Design to Enhance User Experience
Creative Biomart, the leading company in the supply of diagnostic antigens and antibodies, pharmaceutical enzymes, diagnostic enzymes, and high-quality recombinant proteins has launched an intuitive new website design as well as coupon promotion. - April 29, 2015 - Creative Biomart
More Philadelphia Area Hospitals Signing Up for GenToX Pharmacogenomic Testing
Local genetic testing company is experiencing rapid growth with support from the area’s leading medical professionals in joint efforts to bring personalized medical care to patients. - April 23, 2015 - GenToX
GenToX Nominated for Buzz of BIO Award for the Technology of Tomorrow Category
The Award is hosted by Biotechnology Industry Organization at the 2015 BIO International Convention. - April 18, 2015 - GenToX
Peptineo Announces Appointment of Dr. Panganiban to Peptineo to Serve as Chief Science Officer
Peptineo is pleased to announce that Nito Panganiban, Ph.D., has been named Chief Science Officer at Peptineo. Dr. Panganiban will be responsible for cultivating core research capabilities, establishing product development roadmaps, and for communicating with key scientific and customer communities... - March 20, 2015 - Peptineo
Local Pharmacy Wants to Warm Those Less Fortunate
Country Village Chemists of Huntington Asks the Public to Support Their Annual Winter Coat Drive. - February 06, 2015 - North Country Drugs
Boston Healthcare Appoints Andreas H. Sander as Vice President and Managing Director of Boston Healthcare International GmbH
Boston Healthcare today announced the appointment of Andreas Sander as Vice President and Managing Director for Boston Healthcare International GmbH, leading the European team and the firm’s activities in Germany and Europe out of Boston Healthcare’s Berlin office. Mr. Sander brings... - January 21, 2015 - Boston Healthcare
Good News - Creative Biomart Newly Introduced Fucose-Free Protein Expression System
Creative Biomart, a world leading biotech company that specializes in providing advanced tolls for protein expression and purification, today has officially announced its release of novel service--Fucose-free Protein Expression System. According to its official speaker, this service is supported by... - January 07, 2015 - Creative Biomart
Creative Biomart Launches Special Promotion for Christmas and New Year
Creative Biomart, a world leading biotech company that provides recombinant proteins, enzymes and other quality products and services for customers all over the world, has announced today that they would launch a special promotion for Christmas and New year in this very day. According to its... - December 25, 2014 - Creative Biomart
Creative Biomart Newly Introduced Multiplex Protein Detect Assay
Creative Biomart, a world leading biotech company and the commitment of which is to improving people’s life by assisting scientists with their research, has announced today for its official release of Multiplex Protein Detect Assay Service. This release was said to provide better protein... - December 21, 2014 - Creative Biomart
Experimentica Ltd. Licenses Akimba Mouse Model for Diabetic Retinopathy from Lions Eye Institute, Australia
The Lions Eye Institute (LEI) and Experimentica Ltd., a global ophthalmic contract research organization (CRO) announced today that they have entered into an exclusive license agreement for the Akimba mouse model for diabetic retinopathy for contract research. The license agreement was facilitated by Bio-Link Australia, a life sciences commercialisation company. - December 20, 2014 - Experimentica Ltd
Clinical and Economic Impact of Next-Generation Sequencing Examined During Boston Healthcare’s Multi-Stakeholder Symposium
Boston Healthcare Associates, Inc. (BHA) and Cambridge Healthtech Institute (CHI) held an engaging, multi-stakeholder symposium surrounding the unique challenges and opportunities with the use of next-generation sequencing (NGS) in oncology care. Entitled, “Capturing the Value of... - December 12, 2014 - Boston Healthcare
Creative Biomart’s Most-Favored Services List is Available Now
Creative Biomart, a world leading biotech company that offers recombinant proteins, antibodies, antigens and a wide range of biotech services worldwide, today has released its most favored services list officially. It was said that this was done to make them have a better understanding of what... - November 22, 2014 - Creative Biomart
Experimentica Ltd Announces a Strategic Partnership with the Research and Development Center for Ophthalmic Innovations SILK, Tampere, Finland
Experimentica Ltd., a Finland-based ophthalmic CRO, announces a strategic partnership with The Research and Development Center for Ophthalmic Innovations SILK, Tampere, Finland. SILK is a research network composed of research units engaged in basic and clinical eye and vision research. Dr. Giedrius... - November 19, 2014 - Experimentica Ltd
Enzyme Activity Assay Service Are Available in Creative Biomart
Creative Biomart, a world leading supplier of recombinant proteins, antibodies, enzymes and other biotech services for the research community in the field of biology, has announced today for its official release of the novel service-- Enzyme activity assay. This assay is in the aim of assisting... - November 06, 2014 - Creative Biomart
Creative Biomart Newly Introduced It’s Fc Fusion Protein Production Service
Creative Biomart, a word leading Biotech Company had newly released its novel service of Fc Fusion Protein Production Service in the aim of providing more choices for the scientists conducting biomedical and immunology research. The potential clinical application of cytokins to modulate immune... - October 10, 2014 - Creative Biomart
Creative Biomart Morning Talk for Mutagenesis Services
Creative BioMart, a world leading Biotech Company, has conducted a morning talk to discuss its mutagenesis. This talk lasted for nearly one hour. Mutagenesis is a fundamentally important DNA manipulation technique. It involves changing the base sequence of the DNA molecule, usually for the... - September 18, 2014 - Creative Biomart
Creative Biomart Newly Introduced Its Stable Cell Line Service
Creative Biomart today has given an announcement that they would release their new service-stable cell line service in this very day to meet their customer’s need. Stable cell lines are essential for protein and antibody and cell-based assays. But the processes required for the generation of... - September 11, 2014 - Creative Biomart
Creative Biomart Newly Released a Bunch of Over-Expression Lysates
Official marketing staff of Creative Biomart has announced today of their new products release for over-expression lysates. According to its official announcement, this new release is mainly an enhancement of their lysates product. Nearly 9,000 of products have been added in this launch such as... - September 02, 2014 - Creative Biomart
Creative Biomart Introduced Immobilized Enzyme Service
On August 24, 2014, Creative Biomart has introduced their novel service of immobilized enzymes. This novel service is based on a revolutionary new platform, combining affinity tag binding with inert porous materials, designed especially for biocatalysis application in any organic solvent or... - August 27, 2014 - Creative Biomart
Cheers—Creative Biomart Launches High-Throughput Protein Production
The marketing chief staff of Creative Biomart has announced today that they will release the high-throughput protein production service on this very day in the aim of helping speed up their customer’s protein production project. Protein expression is widely used in the production of... - August 22, 2014 - Creative Biomart
Creative Biomart Launches Novel Service for Protein Labeling
On August 18, Creative Biomart had launched a novel service that is site-specific and custom labeling for protein labeling. This new service includes C-terminal labeling, N-terminal labeling, and Labeling at glycosylation sites. The launch of the site-specific and custom labeling service was said... - August 22, 2014 - Creative Biomart
Creative Biomart Signed Industrial Enzymes Agreement
Creative Biomart signed an Industrial Enzymes Agreement with a UK Industrial giant (the name of the company is not allowed to be exposed according to the agreement). On the basis of this agreement, Creative Biomart is going to provide High-temperature Alpha-amylase for beer, Mid-temperature... - August 20, 2014 - Creative Biomart
UCR (Uppsala Clinical Research Center) Selected Ethical eAdjudication® to Support the Clinical Endpoints Adjudication Process
Uppsala Clinical Research Center (UCR), a top Academic Research Organization based in Sweden, adopted Ethical eAdjudication® cloud-based platform to manage the central assessment of Clinical Trial Endpoints by an independent CEC (Clinical Endpoint Classification) Committee. - June 21, 2014 - Ethical GmbH
endpoint Introduces PULSE™ 3.0 Platform for IRT Systems in Clinical Trials
PULSE enables highly customized IRT trial design while maintaining endpoint’s signature 30-Day delivery timeline. - May 23, 2014 - endpoint